HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 79 filers reported holding HARROW HEALTH INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,528,541 | -55.5% | 315,140 | -41.1% | 0.00% | -66.7% |
| Q2 2023 | $10,184,720 | +8.8% | 534,976 | +20.9% | 0.00% | 0.0% |
| Q1 2023 | $9,362,348 | +305160.8% | 442,455 | +112.9% | 0.00% | +200.0% |
| Q4 2022 | $3,067 | -99.9% | 207,831 | +12.4% | 0.00% | 0.0% |
| Q3 2022 | $2,232,000 | +64.4% | 184,935 | -0.9% | 0.00% | – |
| Q2 2022 | $1,358,000 | +16.6% | 186,533 | +9.2% | 0.00% | – |
| Q1 2022 | $1,165,000 | -21.1% | 170,780 | 0.0% | 0.00% | – |
| Q4 2021 | $1,476,000 | -6.0% | 170,780 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $1,570,000 | -2.9% | 172,738 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,617,000 | +111.6% | 174,074 | +54.1% | 0.00% | – |
| Q1 2021 | $764,000 | +131.5% | 112,959 | +134.7% | 0.00% | – |
| Q4 2020 | $330,000 | +33.6% | 48,138 | +8.8% | 0.00% | – |
| Q3 2020 | $247,000 | +34.2% | 44,230 | +25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +139.0% | 35,375 | +159.5% | 0.00% | – |
| Q3 2019 | $77,000 | -54.2% | 13,633 | -29.4% | 0.00% | – |
| Q2 2019 | $168,000 | – | 19,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |